Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy

Radiation Oncology

Jinyi Lang¹  Shichuan Zhang¹  Jie Li¹  Binyu Fu¹  Zixuan Fan¹  Weidong Wang¹  Mei Feng¹ 

[1] Department of Radiation Oncology, Sichuan Cancer Hospital, No. 55, Section 4, South Renmin Rd, Chengdu, Sichuan, People's Republic of China

关键词: Prognostic factor;    Nasopharyngeal carcinoma;    Primary nodal volume;    Primary tumor volume;   

Others  :  1153119
DOI  :  10.1186/1748-717X-8-208

 received in 2013-02-23, accepted in 2013-09-02,  发布年份 2013

【 摘 要 】

Background

To retrospectively analyze whether primary tumor volume and primary nodal volume could be considered independent prognostic factors for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

Methods

Three hundred sixty-three consecutive nasopharyngeal carcinoma (NPC) patients who were stage I-IVa+b and treated with intensity-modulated radiotherapy (IMRT) in our center from October 2003 to October 2005 were analyzed retrospectively. The predictive ability of gender, age, T and N stage, combined chemotherapy, primary tumor and nodal volume for the 5-year local control (LC), distant-metastasis free survival (DMFS) and overall survival (OS) rate were investigated. Primary tumor and nodal volume were measured based on registration of magnetic resonance imaging (MRI) with contrast-enhanced computed tomography (CT) images. The Kaplan–Meier method was used for survival analysis, the log-rank test was used for univariate analyses and the Cox proportional hazard model was used for multivariate prognostic analyses.

Results

The mean value of primary tumor and nodal volume were 31.5 ml and 9.7 ml. The primary tumor and nodal volume were respectively divided into four groups for analysis (primary tumor volume: TV1≤20 ml, 2040 ml; primay nodal volume: NV1≤5 ml, 520 ml). In univariate analysis, the 5-year LC and DMFS rate for TV4 was significantly decreased compared to the other groups (LC: p<0.001, DMFS: p=0.001), the 5-year OS rate for TV3 and TV4 were significantly decreased compared to other two subgroups (p=0.002) and the 5-year regional control (RC), DMFS and OS rate for NV3 and NV4 were significantly less than NV1 and NV2 (RC: p=0.002, DMFS: p=0.01, OS: p=0.014). Multivariate analysis showed that TV>40 ml was an adverse prognostic factor for the 5-year local regional control (LRC) rate (RR 2.454, p=0.002). Primary nodal volume had no statistical significance in predicting 5-year LRC, DMFS and OS rate in multivariate analysis.

Conclusions

Primary tumor volume could predict LRC rate of NPC patients, and the primary tumor volume of 40 ml may be the cut-off. Primary nodal volume may have predictive significance, but more data are needed. These factors should be considered in the TNM staging system of NPC for better estimates of prognosis.

【 授权许可】

   
2013 Feng et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Lee AW, Ng WT, Chan YH: The battle against nasopharyngeal cancer. Radiother Oncol 2012, 104(3):272-278.
• [2]Kam MK, Chau RM, Suen J: Intensity-modulated radiotherapy in nasopharyngeal carcinoma: Dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003, 56:145-157.
• [3]Bilgin KS, Faik Ç, Zzfer Ö: Nasopharyngeal carcinomas: prognostic factors and treatment features. Journal of the Egyptian Nat. Cancer Inst 2008, 20(3):230-236.
• [4]Fletcher GH: Textbook of radiotherapy. Philadelphia: Lea & Febiger; 1973.
• [5]Alexander BM, Othus M, Caglar HB: Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 2011, 79(5):1381-1387.
• [6]Chen CB, Fei ZD, Pan JJ, Bai PG, Chen LS: Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol 2011, 41(4):537-542.
• [7]Chua DT, Sham JS, Kwong DL, Tai KS, Wu PM, Lo M, Yung A, Choy D, Leong L: Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 1997, 39(3):711-719.
• [8]Kim JH, Lee JK: Prognostic value of tumor volume in nasopharyngeal carcinoma. Yonsei Medical Journal 2005, 46(2):221-227.
• [9]Sarisahin M, Cila A, Ozyar E, Yildiz F, Turen S: Prognostic significance of tumor volume in nasopharyngeal carcinoma. Auris Nasus Laryns 2011, 38(2):250-254.
• [10]Chua DT, Sham JS, Leung LH, Tai KS, Au GK: Tumor volume is not an independent prognostic factor in early-stage nasopharyngeal carcinoma treated by radiotherapy alone. Int J Radiat Oncol Biol Phys 2004, 58(5):1437-1444.
• [11]Chung NN, Ting LL, Hsu WC, Lui LT, Wang PM: Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck 2004, 26(3):241-246.
• [12]Emami B, Sethi A, Petruzzelli GJ: Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003, 57(2):481-488.
• [13]Rasch C, Keus R, Pameijer FA, Koops W, de Ru V, Muller S, Touw A, Bartelink H, Herk VM, Lebesque JV: The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1997, 39(4):841-848.
• [14]Rasch C, Steenbakkers R, Herk VM: Target definition in prostate, head, and neck. Semin Radiat Oncol 2005, 15(3):136-145.
• [15]Han L, Lin SJ, Pan JJ, Chen CB, Zhang Y, Zhang XC, Liao XY, Chen QS: Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chinese Journal of Cancer 2010, 29(2):153-158.
• [16]Chen MK, Chen THH, Liu JP, Chang CC, Chie WC: Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer 2004, 15(100):2160-2165.
• [17]Lee CC, Huang TT, Lee MS, Hsiao SH, Lin HY, Su YC, Hsu FC, Hung SK: Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome. Radiation Oncology 2010, 5(20):1-6.